Citric Acid Cycle Explained: Biochemistry of Cellular Respiration

The citric acid cycle is regulated through multiple mechanisms: allosteric modulation by ATP, ADP, NADH, and calcium; feedback inhibition of key enzymes; and covalent phosphorylation of pyruvate dehydrogenase. Pyruvate dehydrogenase responds to acetyl-CoA, fatty acids, NADH, and phosphorylation states. High energy status inhibits the cycle, while low energy activates it. These regulatory layers ensure metabolic adaptation to cellular conditions.

The citric acid cycle is regulated through three main mechanisms: (1) controlling pyruvate decarboxylation to regulate acetyl-CoA entry, and (2) regulating two key allosteric enzymes—Isocitrate dehydrogenase (step 3) and Alpha-ketoglutarate dehydrogenase (step 4)—where ADP activates these enzymes to increase cycle rate when ATP is low, while ATP, NADH, and succinyl-CoA inhibit them to decrease cycle rate when energy is abundant.

The citric acid cycle (Krebs/TCA cycle) is regulated at three key irreversible steps—citrate synthase, isocitrate dehydrogenase, and alpha-ketoglutarate dehydrogenase—through substrate clearance (substrates activate enzymes), product inhibition (products inhibit enzymes), and allosteric regulation (molecules bind to enzyme sites); ATP/NADH inhibit these enzymes while ADP/Ca²⁺ activate them, ensuring metabolic flux matches cellular energy demands.

The citric acid cycle (Krebs cycle) is a central metabolic pathway in mitochondria that oxidizes acetyl-CoA to carbon dioxide while generating high-energy electron carriers NADH and FADH2, which fuel the electron transport chain for ATP production; the cycle consists of eight enzymatic reactions including two oxidative decarboxylation steps (isocitrate dehydrogenase and alpha-ketoglutarate dehydrogenase) that produce NADH, substrate-level phosphorylation (succinyl-CoA synthetase producing GTP), and reversible reactions; the cycle is regulated by feedback inhibition (NADH, ATP, citrate) and activation (ADP, calcium), and serves both catabolic (energy production) and anabolic (biosynthesis precursor supply) functions, with each glucose molecule theoretically yielding approximately 38 ATP through glycolysis, the citric acid cycle, and oxidative phosphorylation.

The citric acid cycle (Krebs cycle) oxidizes acetyl-CoA to CO2 and generates NADH, FADH2, and GTP/ATP. Key steps: (1) Citrate synthase (acetyl-CoA + oxaloacetate to citrate) - inhibited by ATP, NADH, succinyl-CoA, citrate; (2) Isocitrate dehydrogenase (isocitrate to α-ketoglutarate) - activated by ADP, inhibited by ATP and NADH; (3) α-Ketoglutarate dehydrogenase (α-ketoglutarate to succinyl-CoA) - activated by ADP, inhibited by ATP and NADH; (4) Pyruvate dehydrogenase (pyruvate to acetyl-CoA) - inhibited by ATP, acetyl-CoA, NADH.

The citric acid cycle (Krebs cycle) is an amphibolic pathway that serves as the final common oxidative pathway in living cells, where all macromolecules including carbohydrates, amino acids, and lipids are ultimately oxidized; it functions as both a catabolic pathway for energy production and an anabolic pathway by providing intermediates for the synthesis of amino acids, nucleic acids, and heme.

The citric acid cycle is amphibolic, functioning in both catabolism (energy production) and anabolism (biosynthesis). Intermediates serve as precursors: oxaloacetate for aspartate/asparagine, alpha-ketoglutarate for glutamate/glutamine, succinyl-CoA for heme, citrate for fatty acids. Malate can be converted to pyruvate for gluconeogenesis. Oxaloacetate can be converted to aspartate via transamination. These pathways demonstrate how the cycle connects carbohydrate, amino acid, and lipid metabolism.

The citric acid cycle is amphibolic - functioning as both catabolic (energy production) and anabolic (providing biosynthetic intermediates) pathway. Anaplerotic reactions replenish cycle intermediates used for biosynthesis: oxaloacetate for aspartate and non-essential amino acids, alpha-ketoglutarate for glutamate and non-essential amino acids, succinyl-CoA for heme synthesis, and citrate for fatty acid synthesis. The urea cycle and citric acid cycle are interconnected - oxaloacetate from the citric acid cycle can be converted to aspartate for the urea cycle, and fumarate from the urea cycle can re-enter the citric acid cycle.

The Krebs cycle intermediates participate in various anabolic processes: citric acid in fatty acid synthesis, alpha-ketoglutarate in amino acid synthesis, succinyl-CoA in heme group synthesis, malate in glucose synthesis, and oxaloacetate in amino acid synthesis. This dual role makes the cycle amphibolic. The cycle is regulated by citrate synthase (dependent on acetyl-CoA and oxaloacetate availability), isocitric dehydrogenase (activated by ADP, inhibited by ATP and NADH), and alpha-ketoglutarate dehydrogenase. The anaplerotic mechanism maintains intermediate metabolite levels through pyruvate carboxylase, which converts pyruvate to oxaloacetate.

Krebs cycle intermediates serve as precursors for biosynthesis: oxaloacetate and alpha-ketoglutarate are precursors for amino acids; citrate is used for fatty acid and cholesterol synthesis; succinyl-CoA is used for heme (chlorophyll, porphyrin) synthesis; fumarate and malate are involved in various metabolic pathways. This demonstrates the amphibolic nature of the pathway.

Anaplerotic reactions are metabolic pathways that replenish intermediaries in the citric acid cycle to maintain its continuous flow, including the conversion of glutamate to α-ketoglutarate by glutamate dehydrogenase, production of succinyl-CoA from odd-chain fatty acid catabolism, synthesis of oxaloacetate from pyruvate by pyruvate carboxylase (activated by acetyl-CoA), generation of malate by malic enzyme, and degradation of amino acids (glutamate, isoleucine, methionine, threonine, valine, phenylalanine, and tyrosine) to form α-ketoglutarate, succinyl-CoA, and fumarate respectively.

Anaplerotic reactions are metabolic pathways that replenish citric acid cycle intermediates consumed in biosynthetic processes. The video explains that intermediates are continuously used in various synthetic pathways, necessitating replenishment to maintain cycle function. Three key anaplerotic reactions are discussed: pyruvate carboxylase converting pyruvate to oxaloacetate using biotin as a cofactor, phosphoenolpyruvate carboxykinase converting phosphoenolpyruvate to oxaloacetate, and a third reaction involving complete intermediate conversion. These reactions ensure citric acid cycle intermediates remain available for energy production and biosynthesis.

Anaplerotic reactions are metabolic processes that replenish citric acid cycle intermediates when they are removed for biosynthesis; in animals, pyruvate carboxylase converts pyruvate to oxaloacetate using CO2 and ATP, while plants and bacteria use phosphoenolpyruvate carboxylase to convert phosphoenolpyruvate to oxaloacetate, and malate dehydrogenase provides an additional anaplerotic pathway by converting pyruvate to malate using bicarbonate and NADPH.

Anaplerotic reactions are metabolic pathways that replenish intermediates of the Krebs cycle (citric acid cycle) which are consumed during biosynthesis, ensuring the cycle can continue functioning effectively for energy production.

Citric acid cycle intermediates serve as precursors for multiple biosynthetic pathways. Alpha-ketoglutarate is used for amino acid synthesis (glutamate, glutamine, proline, arginine) and neurotransmitter production. Succinyl-CoA is used for heme synthesis (hemoglobin, myoglobin, cytochromes). Citrate is transported to the cytosol for fatty acid and cholesterol synthesis. Anaplerotic reactions replenish citric acid cycle intermediates that are removed for biosynthesis. Phosphoenolpyruvate carboxykinase converts phosphoenolpyruvate to oxaloacetate, replenishing the cycle. Pyruvate carboxylase converts pyruvate to oxaloacetate. These reactions connect glycolysis to the citric acid cycle and are essential for maintaining cycle function during biosynthetic activity.

Deficiencies of Krebs cycle enzymes are associated with various diseases. Aconitase deficiency is associated with optic atrophy. Isocitrate dehydrogenase deficiency is associated with glioblastoma and acute myeloid leukemia. Succinate dehydrogenase deficiency is associated with paragangliomas and gastrointestinal stromal tumors. Fumarase deficiency is associated with encephalopathy and leiomyomatosis. These associations demonstrate how metabolic enzyme deficiencies can lead to specific pathological conditions.

The Krebs cycle (Citric acid cycle/TCA cycle) is a central metabolic pathway that oxidizes acetyl-CoA derived from pyruvate to generate energy carriers (NADH, FADH2) and ATP, with key regulatory enzymes including citrate synthase (activated by ADP, inhibited by ATP/NADH/citrate), isocitrate dehydrogenase (activated by ADP/calcium, inhibited by ATP/NADH), and alpha-ketoglutarate dehydrogenase (similar to pyruvate dehydrogenase complex); enzyme deficiencies such as alpha-ketoglutarate dehydrogenase deficiency cause congenital lactic acidosis, while succinate dehydrogenase mutations are associated with pheochromocytoma and renal cell carcinoma.

The TCA cycle, being a central metabolic pathway, has significant clinical implications when its enzymes malfunction; disorders in TCA cycle enzymes such as isocitrate dehydrogenase, fumarase, and succinate dehydrogenase can lead to cardiovascular diseases, diabetes, non-alcoholic fatty liver disease, arthritis, and neurological disorders including mitochondrial diseases, as these enzymes are crucial for metabolite production and energy metabolism.

Two major irreversible decarboxylation reactions occur in the Krebs cycle: isocitrate dehydrogenase converts isocitrate to alpha-ketoglutarate, releasing CO2 and reducing NAD+ to NADH; alpha-ketoglutarate dehydrogenase converts alpha-ketoglutarate to succinyl-CoA, releasing another CO2 and NADH. Both enzymes are regulated by ATP, NADH, and calcium. Succinyl-CoA synthetase generates GTP through substrate-level phosphorylation (ADP + Pi → ATP). Succinate dehydrogenase (Complex II) reduces FAD to FADH2. Fumarase converts fumarate to malate, and malate dehydrogenase regenerates oxaloacetate while reducing NAD+. Single enzyme deficiencies cause disease: alpha-ketoglutarate dehydrogenase mutations produce 2-hydroxyglutarate, inhibiting histone demethylases and causing glioblastoma; succinate dehydrogenase mutations cause pheochromocytoma; fumarase deficiency causes leiomyomas.

Citric acid cycle intermediates serve as precursors for biosynthesis: oxaloacetate for gluconeogenesis, citrate for fatty acid synthesis, alpha-ketoglutarate for amino acids and purines, and succinyl-CoA for porphyrins. When intermediates are depleted, pyruvate carboxylase replenishes oxaloacetate. Thiamine deficiency impairs pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, causing neurological symptoms since the brain relies exclusively on glucose oxidation. Arsenic and mercury inhibit pyruvate dehydrogenase by binding lipoic acid, impairing aerobic metabolism particularly in the brain. These disorders demonstrate the cycle's critical importance for cellular energy production.